Lee David Uihwan, Shaik Mohammed Rifat, Yerneni Sharmitha, Harmacinski Ashton, Shaik Nishat Anjum, Evey Katie, Bhowmick Kuntal, Mujahid Zainab, Cha Youngjae, Chou Hannah, Yi Andrew, Lee Kijung, Fan Gregory Hongyuan, Malik Raza
Division of Gastroenterology and Hepatology, University of Maryland, 620 W Lexington St, Baltimore, MD 21201, USA.
Liver Center, Division of Gastroenterology, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA.
J Liver Transpl. 2025 May;18. doi: 10.1016/j.liver.2025.100267. Epub 2025 Mar 23.
BACKGROUND & AIMS: Limited data exists on the impact of recipient sex on the post-liver transplant (LT) outcomes in patients with acute-on-chronic liver failure (ACLF). This study aims to utilize a national transplant registry to evaluate the relationship between recipient sex and post-transplant outcomes, stratified by ACLF severity.
The United Network for Organ Sharing Standard Transplant Analysis and Research (UNOS-STAR) database was queried to collect health information on 47,447 patients who underwent liver transplantation between 1987 and 2019. The cohort was stratified by biological sex, and further subdivided into groups based on ACLF severity: Grade 0 (without ACLF) and Grade 1-3 in increasing severity. The primary outcomes assessed were all-cause mortality and graft failure while secondary outcomes included specific causes of death.
No sex-based disparities were observed in the primary outcomes of all-cause mortality and graft failure across all grades of ACLF. However, females without ACLF exhibited a higher risk of mortality from recurrent graft disease compared to males. Time-point analyses revealed higher 180-day and 360-day mortality rates in females without ACLF. Among patients with ACLF Grade 1, females demonstrated higher 30-day mortality, but no significant differences were found at 90-, 180- or 360-days. Among patients with ACLF Grades 2 and 3, however, no sex-based differences in 30-day to 360-day mortality were identified.
Factors other than sex appear to play a more critical role in determining the long-term transplant outcomes in ACLF. The increased short-term mortality observed in females with ACLF grade 1 warrants further investigation to elucidate potential contributing factors.
关于受者性别对慢性肝衰竭急性发作(ACLF)患者肝移植(LT)后结局的影响,现有数据有限。本研究旨在利用全国移植登记系统评估受者性别与移植后结局之间的关系,并按ACLF严重程度进行分层。
查询器官共享联合网络标准移植分析与研究(UNOS-STAR)数据库,收集1987年至2019年间接受肝移植的47447例患者的健康信息。该队列按生物性别分层,并根据ACLF严重程度进一步细分为:0级(无ACLF)和1-3级,严重程度递增。评估的主要结局为全因死亡率和移植物失败,次要结局包括具体死亡原因。
在所有等级的ACLF中,全因死亡率和移植物失败的主要结局未观察到基于性别的差异。然而,与男性相比,无ACLF的女性因复发性移植物疾病导致死亡的风险更高。时间点分析显示,无ACLF的女性180天和360天死亡率更高。在ACLF 1级患者中,女性30天死亡率更高,但在90天、180天或360天时未发现显著差异。然而,在ACLF 2级和3级患者中,未发现30天至360天死亡率存在基于性别的差异。
性别以外的因素似乎在决定ACLF患者的长期移植结局中起更关键的作用。ACLF 1级女性观察到的短期死亡率增加值得进一步研究,以阐明潜在的促成因素。